Purification Upsell Gilson’s core purification capabilities in preparative HPLC, automated SPE, and GPC clean-up, complemented by the VERITY 3240 pump launch, signal a strong opportunity to upsell scalable purification workflows. Target pharmaceutical, biotech, environmental, clinical, food & beverage, and forensic labs with bundled purification systems, consumables, and maintenance plans; propose pilot programs to demonstrate productivity gains in early drug discovery and scale-up.

Automation Integration Leverage Gilson’s automation and digital tools to offer integrated lab automation packages that couple liquid handling with purification instruments. Highlight value around throughput, reproducibility, and data integrity; bundle pipetting solutions with HPLC, SPE and GPC workflows and provide validation, calibration, and remote monitoring services aligned with customers’ procurement processes.

Global Service Global sales and service footprint enables regional account targeting and service contracts. Focus on labs expanding operations or establishing regional R&D hubs and CROs; offer multi-site support, spare parts catalogs, training programs, and on-site maintenance to reduce downtime and total cost of ownership.

Drug Discovery Focus A strong emphasis on early drug discovery creates opportunities to collaborate with CROs and pharmaceutical companies needing reliable scale-up purification and process development. Propose joint development projects, pilot scale purification lines, and access to modular purification platforms that can grow with projects from discovery to preclinical.

Service Compliance Durability, modularity, and user-friendly design provide a defensible case for service contracts, calibration, and qualification packages, including IQ/OQ/PQ for regulated labs. Offer extended warranties, calibration services, and validated methods to support GMP/GLP environments and long product lifecycles.